Ardent Health Partners (NYSE:ARDT) Earns Neutral Rating from JPMorgan Chase & Co.

Ardent Health Partners (NYSE:ARDT)‘s stock had its “neutral” rating reiterated by stock analysts at JPMorgan Chase & Co. in a report issued on Tuesday, MarketBeat Ratings reports. They currently have a $20.00 price objective on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 23.76% from the stock’s current price.

ARDT has been the subject of several other reports. Leerink Partners boosted their price target on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and dropped their target price for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research note on Thursday, November 14th. Stephens reissued an “overweight” rating and set a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. Finally, KeyCorp initiated coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price on the stock. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Ardent Health Partners has an average rating of “Buy” and an average price target of $22.00.

Ardent Health Partners Stock Performance

Shares of ARDT opened at $16.16 on Tuesday. Ardent Health Partners has a fifty-two week low of $14.57 and a fifty-two week high of $20.72. The business has a 50 day simple moving average of $17.37. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Institutional Investors Weigh In On Ardent Health Partners

Large investors have recently modified their holdings of the stock. BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the 3rd quarter valued at approximately $42,000. Financial Management Professionals Inc. purchased a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $50,000. MetLife Investment Management LLC bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $135,000. Quadrature Capital Ltd bought a new stake in shares of Ardent Health Partners during the third quarter valued at approximately $229,000. Finally, Barclays PLC bought a new position in Ardent Health Partners in the third quarter worth $385,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.